Status:
WITHDRAWN
Bevacizumab and Retinal Vascular Occlusions
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Conditions:
Edema Macular
Vascular Occlusion
Eligibility:
All Genders
40-90 years
Phase:
PHASE3
Brief Summary
To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.
Eligibility Criteria
Inclusion
- Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography
Exclusion
- Previous surgery
- Uveitis
- Glaucoma
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00347711
Start Date
June 1 2006
End Date
June 1 2006
Last Update
June 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asociacion para Evitar la Ceguera en Mexico
México, D.F. Mexico, Mexico, 04030